Hangzhou Greatstar Industrial Co., Ltd (SWX:GSI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions CHF. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jul 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Dec 31, 2021	Dec 31, 2020
Market Capitalization	4,153	4,797	3,194	3,039	4,980	4,488
Market Cap Growth	14.44%	50.18%	5.10%	-38.97%	10.97%	182.22%
Enterprise Value	3,793	4,501	2,884	3,077	5,041	4,418
Last Close Price	11.37	12.69	11.44	13.46	-	-
PE Ratio	14.50	16.77	15.90	15.97	27.33	24.53
PS Ratio	2.25	2.61	2.46	1.80	3.18	3.88
PB Ratio	1.99	2.33	1.79	1.66	3.21	3.66
P/TBV Ratio	2.55	2.96	2.37	2.21	4.55	5.18
P/FCF Ratio	-	30.87	15.94	18.90	-	226.93
P/OCF Ratio	-	22.21	12.65	13.89	1862.52	42.94
EV/Sales Ratio	2.24	2.45	2.22	1.82	3.22	3.82
EV/EBITDA Ratio	12.32	13.88	14.19	13.89	27.92	21.92
EV/EBIT Ratio	14.27	15.42	16.65	15.96	33.05	24.32
EV/FCF Ratio	21.76	28.97	14.39	19.14	-	223.43
Debt / Equity Ratio	0.13	0.22	0.16	0.21	0.38	0.31
Debt / EBITDA Ratio	0.83	1.32	1.30	1.61	3.03	1.85
Debt / FCF Ratio	1.59	2.87	1.40	2.36	-	19.26
Asset Turnover	0.71	0.69	0.57	0.70	0.71	0.69
Inventory Turnover	3.74	3.62	2.78	3.30	3.89	4.62
Quick Ratio	1.95	1.70	1.86	1.93	1.32	1.90
Current Ratio	2.63	2.21	2.49	2.76	1.90	2.45
Return on Equity (ROE)	14.87%	14.97%	11.84%	11.83%	13.07%	16.39%
Return on Assets (ROA)	6.91%	6.87%	4.76%	5.01%	4.29%	6.75%
Return on Capital (ROIC)	7.82%	7.83%	5.39%	5.74%	4.97%	7.85%
Return on Capital Employed (ROCE)	13.50%	13.80%	9.40%	9.70%	8.70%	12.40%
Earnings Yield	6.90%	5.96%	6.29%	6.26%	3.66%	4.08%
FCF Yield	4.20%	3.24%	6.28%	5.29%	-1.51%	0.44%
Dividend Yield	2.17%	0.24%	0.29%	0.10%	-	-
Payout Ratio	32.61%	34.05%	28.48%	5.04%	4.16%	3.21%
Buyback Yield / Dilution	0.00%	0.00%	-4.70%	-1.50%	-4.05%	-1.37%
Total Shareholder Return	2.17%	0.25%	-4.42%	-1.41%	-4.05%	-1.37%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.